A short protocol using dexamethasone and monophosphoryl lipid A generates tolerogenic dendritic cells that display a potent migratory capacity to lymphoid chemokines

BACKGROUND: Generation of tolerogenic dendritic cells (TolDCs) for therapy is challenging due to its implications for the design of protocols suitable for clinical applications, which means not only using safe products, but also working at defining specific biomarkers for TolDCs identification, deve...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: García-González, Paulina, Morales, Rodrigo, Hoyos, Lorena, Maggi, Jaxaira, Campos, Javier, Pesce, Bárbara, Gárate, David, Larrondo, Milton, González, Rodrigo, Soto, Lilian, Ramos, Verónica, Tobar, Pía, Molina, María Carmen, Pino-Lagos, Karina, Catalán, Diego, Aguillón, Juan Carlos
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2013
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3674980/
https://ncbi.nlm.nih.gov/pubmed/23706017
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1479-5876-11-128
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados